Finally, the analysis of HCC1806_sh6 xenograft tumors by immunofluorescent staining revealed that MLK4 knock-down was associated with persistent H2AX phosphorylation in tumor tissues after the treatment with doxorubicin in vivo (Fig. 4F, G). The gene discussed is MAP3K21; the disease is neoplasm.